07708994 is referenced by 36 patents and cites 75 patents.

The present application describes therapy with antagonists which bind to B cell surface markers, such as CD20. In particular, the application describes the use of such antagonists to treat autoimmune disease in a mammal who experiences an inadequate response to a TNFα-inhibitor.

Title
Therapy of autoimmune disease in a patient with an inadequate response to a TNF-α inhibitor
Application Number
11/439906
Publication Number
7708994 (B2)
Application Date
May 24, 2006
Publication Date
May 4, 2010
Inventor
Mark C Benyunes
San Francisco
CA, US
Agent
Wendy M Lee
Assignee
Genentech
CA, US
IPC
C07K 16/00
A61K 39/395
View Original Source